|
|
Name: |
ORBIMED ADVISORS LLC |
City: |
NEW YORK |
State: |
NY |
Zip: |
10017 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
27 |
|
View All Holdings |
Currently
Viewing:
Decreased Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
BMRN |
Biomarin Pharmaceutical Inc |
7 |
- |
$88.63 |
$151,515,000 |
1,571,410 |
3.03% |
8,601,000 |
-43,800 |
0.834 |
Drug Manufacturers - ... |
|
RYZB |
Rayzebio, Inc. |
8 |
- |
$62.49 |
$147,045,000 |
2,365,213 |
2.95% |
88,816,000 |
-257,696 |
3.891 |
N/A |
|
SWTX |
Springworks Therapeutics, Inc. |
10 |
- |
$0.00 |
$117,507,000 |
3,219,359 |
2.35% |
25,753,000 |
-749,229 |
4.631 |
N/A |
|
IONS |
Ionis Pharmaceuticals Inc |
12 |
- |
$41.97 |
$104,458,000 |
2,064,797 |
2.09% |
6,049,000 |
-104,703 |
1.478 |
Drug Manufacturers - ... |
|
IRON |
Disc Medicine, Inc |
13 |
- |
$29.79 |
$98,321,000 |
1,702,237 |
1.97% |
-8,307,000 |
-567,400 |
9.777 |
N/A |
|
EVH |
Evolent Health, Inc. |
16 |
- |
$27.10 |
$90,718,000 |
2,746,532 |
1.82% |
11,870,000 |
-149,100 |
2.351 |
N/A |
|
UTHR |
United Therapeutics Corp |
17 |
- |
$262.40 |
$84,900,000 |
386,100 |
1.7% |
-5,877,000 |
-15,800 |
0.817 |
Drug Manufacturers - ... |
|
CRNX |
Crinetics Pharmaceuticals, ... |
31 |
- |
$47.20 |
$59,325,000 |
1,667,360 |
1.19% |
-26,804,000 |
-1,228,714 |
2.874 |
N/A |
|
APLS |
Apellis Pharmaceuticals Inc |
32 |
- |
$47.46 |
$55,203,000 |
922,200 |
1.11% |
7,254,000 |
-338,300 |
0.806 |
N/A |
|
KROS |
Keros Therapeutics, Inc. |
35 |
- |
$0.00 |
$50,445,000 |
1,268,734 |
1.01% |
2,155,000 |
-246,000 |
3.734 |
N/A |
|
HUM |
Humana Inc |
36 |
- |
$320.54 |
$50,313,000 |
109,900 |
1.01% |
-116,320,000 |
-232,600 |
0.083 |
Health Care Plans |
|
ALPN |
Alpine Immune Sciences Inc |
38 |
- |
$64.60 |
$48,322,000 |
2,535,245 |
0.97% |
1,588,000 |
-1,546,347 |
5.522 |
N/A |
|
NPCE |
Neuropace Inc |
42 |
- |
$13.64 |
$41,281,000 |
4,003,967 |
0.83% |
2,242,000 |
-8,314 |
16.484 |
N/A |
|
APGE |
Apogee Therapeutics, Inc. |
48 |
- |
$54.19 |
$35,705,000 |
1,277,901 |
0.72% |
5,291,000 |
-150,000 |
3.436 |
N/A |
|
SLRN |
Acelyrin, Inc. |
54 |
- |
$4.35 |
$29,853,000 |
4,001,711 |
0.6% |
-24,315,000 |
-1,324,591 |
4.117 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
56 |
- |
$0.00 |
$25,333,000 |
550,000 |
0.51% |
-7,419,000 |
-408,793 |
0.879 |
N/A |
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
57 |
- |
$43.76 |
$24,669,000 |
536,642 |
0.49% |
11,289,000 |
-47,000 |
0.875 |
N/A |
|
PMVP |
Pmv Pharmaceuticals, Inc. |
61 |
- |
$0.00 |
$20,073,000 |
6,475,291 |
0.4% |
-20,224,000 |
-87,786 |
11.904 |
N/A |
|
ADGI |
Adagio Therapeutics, Inc. |
65 |
- |
$2.42 |
$16,263,000 |
4,127,565 |
0.33% |
7,303,000 |
-1,142,835 |
3.71 |
N/A |
|
ARWR |
Arrowhead Pharmaceuticals Inc |
76 |
- |
$24.44 |
$9,781,000 |
319,651 |
0.2% |
-1,871,000 |
-114,000 |
0.312 |
Business Services |
|
QURE |
uniQure B.V. |
77 |
- |
$4.69 |
$9,125,000 |
1,347,900 |
0.18% |
-4,727,000 |
-716,555 |
3.029 |
N/A |
|
APLM |
Apollomics Ord Shs Class A |
79 |
- |
$0.00 |
$8,266,000 |
8,565,456 |
0.17% |
-59,120,000 |
-9,428,179 |
94.023 |
N/A |
|
RAPT |
Rapt Therapeutics, Inc. |
83 |
- |
$8.33 |
$6,993,000 |
281,413 |
0.14% |
-13,698,000 |
-963,532 |
0.779 |
N/A |
|
ORIC |
Oric Pharmaceuticals, Inc. |
88 |
- |
$0.00 |
$4,811,000 |
522,968 |
0.1% |
-596,000 |
-370,700 |
1.33 |
N/A |
|
KZR |
Kezar Life Sciences, Inc. |
96 |
- |
$0.86 |
$1,826,000 |
1,927,000 |
0.04% |
-4,675,000 |
-3,536,000 |
2.818 |
N/A |
|
YS |
Ys Biopharma Ord Shs |
98 |
- |
$0.00 |
$1,654,000 |
3,236,311 |
0.03% |
-1,979,000 |
-1,305,111 |
3.478 |
N/A |
|
PHGE |
BiomX Inc |
100 |
- |
$0.00 |
$1,265,000 |
4,517,589 |
0.03% |
-338,000 |
-35,900 |
19.779 |
N/A |
|